Expectations for synergistically favorable effects of the combination therapy with DPP-4 inhibitor and SGLT2 inhibitor on cholesterol synthesis and absorption

被引：0
作者：
Jojima, Teruo [1 ]
机构：
[1] Dokkyo Med Univ, Dept Endocrinol & Metab, 880 Kita Kobayashi, Mibu, Tochigi 3210293, Japan
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2021年 / 333卷
关键词：
D O I：
10.1016/j.ijcard.2021.03.030
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：213 / 213
页数：1
相关论文
共 3 条
  • [1] Differences in lipid metabolism between anagliptin and sitagliptin in patients with type 2 diabetes on statin therapy: a secondary analysis of the REASON trial
    Chihara, Atsuko
    Tanaka, Atsushi
    Morimoto, Takeshi
    Sakuma, Mio
    Shimabukuro, Michio
    Nomiyama, Takashi
    Arasaki, Osamu
    Ueda, Shinichiro
    Node, Koichi
    [J]. CARDIOVASCULAR DIABETOLOGY, 2019, 18 (01)
  • [2] SGLT2 inhibitor/DPP-4 inhibitor combination therapy - complementary mechanisms of action for management of type 2 diabetes mellitus
    Dey, Jayant
    [J]. POSTGRADUATE MEDICINE, 2017, 129 (04) : 409 - 420
  • [3] JOJIMA T, 2021, INT J CARDIOL
1